Search Results for

*

1-25 of 55 Results
Sort by Relevance , Date , Title

ACC/AHA Release Updated Guideline on the Treatment of Blood Cholesterol to Reduce ASCVD...

Aug 15, 2014 - The Blood Cholesterol Expert Panel from the American College of Cardiology (ACC) and the American Heart Association (AHA) issued an updated evidence-based guideline in 2013 that addresses the use of fixed doses of cholesterol-lowering drugs (statins) to reduce the risk of ASCVD in ...

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2014/0815/p260.html

ACP Releases Guideline on Lipid Control in Patients with Type 2 Diabetes Mellitus - ...

Aug 15, 2004 - A guideline on the management of dyslipidemia, particularly hypercholesterolemia, in patients with type 2 diabetes mellitus has been published by the Clinical Efficacy Assessment Subcommittee of the American College of Physicians (ACP).

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2004/0815/p775.html

AHA Publishes Statement on Drug Therapy for Lipid Abnormalities in Children and ...

Mar 1, 2008 - The American Heart Association (AHA) has published a scientific statement on drug therapy for the treatment of high-risk lipid abnormalities in children and adolescents.

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2008/0301/p694.html

Alirocumab (Praluent) for Treatment of Hyperlipidemia - STEPS - American Family Physician

Aug 15, 2016 - Alirocumab is a novel lipid-lowering therapy that is highly effective at lowering LDL cholesterol when used in addition to statin therapy and diet. Its use should be limited to patients with either heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular ...

American Family Physician : STEPS

https://www.aafp.org/afp/2016/0815/p310.html

Alternative Therapies: Part II. Congestive Heart Failure and Hypercholesterolemia - ...

Sep 15, 2000 - Natural supplements are widely used by the American public but, while claims of their therapeutic effects abound, medical research does not always support their effectiveness. Clinical trials using Q10 for the management of congestive heart failure have had conflicting results; hawthorn...

American Family Physician : Article

https://www.aafp.org/afp/2000/0915/p1325.html

Amlodipine/Atorvastin (Caduet) for Preventing Heart Disease - STEPS - American Family ...

Mar 15, 2006 - Amlodipine/atorvastatin offers no added benefit in safety, tolerability, or effectiveness over amlodipine and atorvastatin taken separately. It has not been shown to improve mortality or morbidity in patients who have hypertension with or without dyslipidemia. The only potential ...

American Family Physician : STEPS

https://www.aafp.org/afp/2006/0315/p1067.html

Best Alternatives to Statins for Treating Hyperlipidemia - FPIN's Clinical Inquiries - ...

Oct 1, 2007 - Most alternatives to statin therapy reduce cholesterol levels but do not consistently demonstrate a reduction in cardiac-related and all-cause mortality in patients with or without coronary heart disease (CHD). Fibrates and niacin decrease the risk of major coronary events; however, no ...

American Family Physician : FPIN's Clinical Inquiries

https://www.aafp.org/afp/2007/1001/p1027.html

Cholesterol Management: ACC/AHA Updates Guideline - Practice Guidelines - American ...

May 1, 2019 - The American College of Cardiology/American Heart Association (ACC/AHA) task force on clinical practice guidelines has updated its 2013 cholesterol guideline.

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2019/0501/p589.html

Cholesterol Treatment Guidelines Update - American Family Physician

Mar 1, 2002 - Hypercholesterolemia is one of the major contributors to atherosclerosis and coronary heart disease in our society. The National Cholesterol Education Program of the National Institutes of Health has created a set of guidelines that standardize the clinical assessment and management of ...

American Family Physician : Article

https://www.aafp.org/afp/2002/0301/p871.html

Choosing Drug Therapy for Patients with Hyperlipidemia - American Family Physician

Jun 1, 2000 - Almost 13 million American adults require drug therapy to meet the low-density lipoprotein goals set by the National Cholesterol Education Program. Attempts to achieve these goals through diet and exercise are often unsuccessful. Major studies in recent years have demonstrated that ...

American Family Physician : Article

https://www.aafp.org/afp/2000/0601/p3371.html

Colesevelam (WelChol) for Reduction of LDL Cholesterol - STEPS - American Family Physician

Jul 15, 2005 - Colesevelam lowers LDL cholesterol levels a small amount (7 to 16 percent) when used alone and provides additional cholesterol lowering when added to statin therapy. It has a slightly beneficial effect on HDL cholesterol levels, has no effect on triglyceride levels, and is well tolerated.

American Family Physician : STEPS

https://www.aafp.org/afp/2005/0715/p321.html

Diet and Exercise in the Management of Hyperlipidemia - American Family Physician

May 1, 2010 - Dietary factors that influence lipid levels include modification of nutritional components, consumption of specific foods, use of food additives and supplements, and major dietary approaches. The most beneficial changes result from reducing intake of saturated and trans fats; increasing...

American Family Physician : Article

https://www.aafp.org/afp/2010/0501/p1097.html

Dietary Therapy for Children with Hypercholesterolemia - American Family Physician

Feb 1, 2000 - Accumulating evidence clearly shows that atherosclerosis begins in youth. The National Cholesterol Education Program (NCEP) has recommended that children at high risk of developing coronary artery disease as adults be screened so that those with elevated low-density lipoprotein (LDL) ...

American Family Physician : Article

https://www.aafp.org/afp/2000/0201/p675.html

Effective Use of Statins to Prevent Coronary Heart Disease - American Family Physician

Jan 15, 2001 - Primary and secondary prevention trials have shown that use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (also known as statins) to lower an elevated low-density lipoprotein cholesterol level can substantially reduce coronary events and death from coronary heart ...

American Family Physician : Article

https://www.aafp.org/afp/2001/0115/p309.html

Effects of Omega-3 Fatty Acids on Cardiovascular Health - Editorials - American Family ...

Jul 1, 2004 - Advertisement << Previous article Next article >> Jul 1, 2004 Issue Effects of Omega-3 Fatty Acids on Cardiovascular Health LAWRENCE J. APPEL, M.D., M.P.H. Johns Hopkins Medical Institutions Baltimore, Maryland Am Fam Physician. 2004 Jul ;70(1):34-35. Related Article The potential...

American Family Physician : Editorials

https://www.aafp.org/afp/2004/0701/p34.html

Endocrine Society Releases Guidelines on Diagnosis and Management of ...

Jul 15, 2013 - The Endocrine Society recently published evidence-based recommendations on the diagnosis and management of hypertriglyceridemia in adults. Contributing factors include overweight and obesity, physical inactivity, excessive alcohol intake, metabolic syndrome, type 2 diabetes mellitus, ...

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2013/0715/p142.html

Evolocumab (Repatha) for the Treatment of Hyperlipidemia - STEPS - American Family ...

Nov 15, 2016 - Evolocumab is generally safe and effective at lowering serum LDL cholesterol levels for select patients who need marked cholesterol reduction and can tolerate injections. However, it remains unknown whether evolocumab prevents premature death from cardiovascular events.

American Family Physician : STEPS

https://www.aafp.org/afp/2016/1115/p843.html

Ezetimibe for Hypercholesterolemia. - STEPS - American Family Physician

Oct 15, 2003 - Ezetimibe is safe and effective for lowering LDL cholesterol and triglyceride levels, but has not been shown to affect patient-oriented outcomes. It can be used as monotherapy or in combination with a low-dose statin, although the combination is more expensive than the maximum dose of ...

American Family Physician : STEPS

https://www.aafp.org/afp/2003/1015/p1595.html

Ezetimibe/Simvastatin (Vytorin) for Hypercholesterolemia - STEPS - American Family ...

Nov 15, 2005 - Low doses of ezetimibe/simvastatin provide greater improvements in lipid profile than simvastatin or atorvastatin monotherapy. Ezetimibe/simvastatin may be useful in patients who are unable to tolerate high-dose statin therapy. Combination ezetimibe-simvastatin is less expensive than ...

American Family Physician : STEPS

https://www.aafp.org/afp/2005/1115/p2081.html

Fish Oil for Treatment of Dyslipidemia - FPIN's Clinical Inquiries - American Family ...

Feb 15, 2014 - Supplementation with omega-3 fatty acids decreases triglyceride and very low-density lipoprotein cholesterol levels. However, it can also increase low-density lipoprotein (LDL) cholesterol levels. Treatment with omega-3 fatty acids does not decrease total mortality, cardiovascular ...

American Family Physician : FPIN's Clinical Inquiries

https://www.aafp.org/afp/2014/0215/p288.html

For Hyperlipidemia, Go Where the Evidence Takes You: Give a Statin and Nothing Else - ...

Nov 1, 2010 - Only statins have patient-oriented evidence supporting their role in reducing all-cause mortality. The NCEP–ATP III guidelines offer a nine-step approach for reaching target lipid levels, but the application to everyday practice is far simpler: If a patient with hyperlipidemia has ...

American Family Physician : Editorials: Controversies in Family Medicine

https://www.aafp.org/afp/2010/1101/p1063.html

Hyperlipidemia Treatment in Children: The Younger, the Better - Editorials: ...

Sep 1, 2010 - Despite the absence of data in children demonstrating morbidity and mortality reduction by aggressive treatment of lipid disorders, the overwhelming data in adults (e.g., decreasing LDL cholesterol, improved morbidity and mortality) and evidence of atherosclerotic lesions developing in ...

American Family Physician : Editorials: Controversies in Family Medicine

https://www.aafp.org/afp/2010/0901/p460.html

Hyperlipidemia: Drugs for Cardiovascular Risk Reduction in Adults - American Family ...

Jan 15, 2017 - Guidelines from the American College of Cardiology/American Heart Association (ACC/AHA) and the U.K. National Institute for Health and Care Excellence (NICE) indicate that lipid-lowering drugs have benefit for primary and secondary prevention of atherosclerotic cardiovascular disease ...

American Family Physician : Article

https://www.aafp.org/afp/2017/0115/p78.html

Icosapent Ethyl (Vascepa) for Hyperlipidemia/Hypercholesterolemia to Reduce Risk of ... Restricted content. Login required.

Jan 15, 2021 - Icosapent ethyl is safe, well tolerated and effective in preventing ischemic events including stroke and heart attack.

American Family Physician : STEPS

https://www.aafp.org/afp/2021/0115/p117.html

Improvment in Current Approaches to Lipid Lowering - Editorials - American Family ...

Mar 1, 2002 - Advertisement << Previous article Next article >> Mar 1, 2002 Issue Editorials Improvement in Current Approaches to Lipid Lowering BENJAMIN J. ANSELL, M.D., University of California, Los Angeles, School of Medicine Los Angeles, California Am Fam Physician. 2002 Mar 1;65(5):783-787....

American Family Physician : Editorials

https://www.aafp.org/afp/2002/0301/p783.html

navigate_before 1 2 3 navigate_next

25 50 100 results per page